These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 21563866)

  • 1. Aripiprazole and haloperidol in the treatment of delirium.
    Boettger S; Friedlander M; Breitbart W; Passik S
    Aust N Z J Psychiatry; 2011 Jun; 45(6):477-82. PubMed ID: 21563866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An open trial of aripiprazole for the treatment of delirium in hospitalized cancer patients.
    Boettger S; Breitbart W
    Palliat Support Care; 2011 Dec; 9(4):351-7. PubMed ID: 22104410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Haloperidol, risperidone, olanzapine and aripiprazole in the management of delirium: A comparison of efficacy, safety, and side effects.
    Boettger S; Jenewein J; Breitbart W
    Palliat Support Care; 2015 Aug; 13(4):1079-85. PubMed ID: 25191793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aripiprazole in the treatment of delirium.
    Straker DA; Shapiro PA; Muskin PR
    Psychosomatics; 2006; 47(5):385-91. PubMed ID: 16959926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination treatment with aripiprazole and valproic acid for acute mania: an 8-week, single-blind, randomized controlled trial.
    Jeong HG; Lee MS; Ko YH; Han C; Jung IK
    Clin Neuropharmacol; 2012; 35(3):97-102. PubMed ID: 22592508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial.
    Barbui C; Accordini S; Nosè M; Stroup S; Purgato M; Girlanda F; Esposito E; Veronese A; Tansella M; Cipriani A;
    J Clin Psychopharmacol; 2011 Jun; 31(3):266-73. PubMed ID: 21508849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aripiprazole in the treatment of delirium.
    Alao AO; Soderberg M; Pohl EL; Koss M
    Int J Psychiatry Med; 2005; 35(4):429-33. PubMed ID: 16673842
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intramuscular aripiprazole or haloperidol and transition to oral therapy in patients with agitation associated with schizophrenia: sub-analysis of a double-blind study.
    Andrezina R; Marcus RN; Oren DA; Manos G; Stock E; Carson WH; McQuade RD
    Curr Med Res Opin; 2006 Nov; 22(11):2209-19. PubMed ID: 17076982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy, safety, and tolerability of aripiprazole for the treatment of schizoaffective disorder: results from a pooled analysis of a sub-population of subjects from two randomized, double-blind, placebo-controlled, pivotal trials.
    Glick ID; Mankoski R; Eudicone JM; Marcus RN; Tran QV; Assunção-Talbott S
    J Affect Disord; 2009 May; 115(1-2):18-26. PubMed ID: 19230981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trial of aripiprazole in the treatment of first-episode schizophrenia.
    Lee HY; Ham BJ; Kang RH; Paik JW; Hahn SW; Lee MS; Lee MS
    Psychiatry Clin Neurosci; 2010 Feb; 64(1):38-43. PubMed ID: 20416024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenomenology of the subtypes of delirium: phenomenological differences between hyperactive and hypoactive delirium.
    Boettger S; Breitbart W
    Palliat Support Care; 2011 Jun; 9(2):129-35. PubMed ID: 24468480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of oral aripiprazole compared with haloperidol in patients transitioning from acute treatment with intramuscular formulations.
    Daniel DG; Currier GW; Zimbroff DL; Allen MH; Oren D; Manos G; McQuade R; Pikalov AA; Crandall DT
    J Psychiatr Pract; 2007 May; 13(3):170-7. PubMed ID: 17522560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Effects of mianserin hydrochloride on delirium: comparison with the effects of oxypertine and haloperidol].
    Nakamura J; Uchimura N; Yamada S; Nakazawa Y
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1994 Aug; 14(4):269-77. PubMed ID: 7975931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Aripiprazole and delirium.
    Alao AO; Moskowitz L
    Ann Clin Psychiatry; 2006; 18(4):267-9. PubMed ID: 17162627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A double-blind trial of haloperidol, chlorpromazine, and lorazepam in the treatment of delirium in hospitalized AIDS patients.
    Breitbart W; Marotta R; Platt MM; Weisman H; Derevenco M; Grau C; Corbera K; Raymond S; Lund S; Jacobson P
    Am J Psychiatry; 1996 Feb; 153(2):231-7. PubMed ID: 8561204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of safety, tolerability and effectiveness of adjunctive aripiprazole to lithium/valproate in bipolar mania: a 46-week, open-label extension following a 6-week double-blind study.
    Vieta E; Owen R; Baudelet C; McQuade RD; Sanchez R; Marcus RN
    Curr Med Res Opin; 2010 Jun; 26(6):1485-96. PubMed ID: 20429835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Aripiprazole and haloperidol: beneficial combination antipsychotic therapy for a schizophrenic patient.
    Kuo J; Hwu HG
    Clin Neuropharmacol; 2008; 31(3):173-5. PubMed ID: 18520984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An open-label study of the efficacy and tolerability of aripiprazole for children and adolescents with tic disorders.
    Yoo HK; Choi SH; Park S; Wang HR; Hong JP; Kim CY
    J Clin Psychiatry; 2007 Jul; 68(7):1088-93. PubMed ID: 17685747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of aripiprazole on cognition in the treatment of patients with schizophrenia.
    Riedel M; Spellmann I; Schennach-Wolff R; Musil R; Dehning S; Cerovecki A; Opgen-Rhein M; Matz J; Seemüller F; Obermeier M; Severus E; Engel RR; Müller N; Möller HJ
    Pharmacopsychiatry; 2010 Mar; 43(2):50-7. PubMed ID: 20336597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aripiprazole for Tourette's syndrome: a systematic review and meta-analysis.
    Zheng W; Li XB; Xiang YQ; Zhong BL; Chiu HF; Ungvari GS; Ng CH; Lok GK; Xiang YT
    Hum Psychopharmacol; 2016 Jan; 31(1):11-8. PubMed ID: 26310194
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.